Codex DNA to Present at the 2022 Jefferies Healthcare Conference
Codex DNA (Nasdaq: DNAY) will present at the 2022 Jefferies Healthcare Conference on June 10 at 9:00 AM Eastern Time. The presentation will be available via live webcast on the company's investor relations page. An archived version will be accessible for 30 days post-event. Codex DNA specializes in automated synthetic biology systems, enabling rapid and error-free DNA and mRNA synthesis. Their innovative BioXp™ system is transforming workflows in precision medicine, drug discovery, and gene therapy.
- None.
- None.
SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that Todd R. Nelson, PhD, the company’s chief executive officer, will present at the 2022 Jefferies Healthcare Conference on Friday, June 10th at 9:00 am Eastern time / 6:00 am Pacific Time.
The presentation will be webcast live and can be accessed through a link on the investors section of Codex DNA’s website at https://ir.codexdna.com. An archived replay of each webcast will be available for 30 days following the event.
About Codex DNA
Codex DNA is empowering scientists with the ability to create novel, synthetic biology-enabled solutions for many of humanity’s greatest challenges. As inventors of the industry-standard Gibson Assembly® method and the first commercial automated benchtop DNA and mRNA synthesis system, Codex DNA is enabling rapid, accurate, and reproducible writing of DNA and mRNA for numerous downstream markets. The company’s award-winning BioXp™ system consolidates, automates, and optimizes the entire synthesis, cloning, and amplification workflow. As a result, it delivers virtually error-free synthesis of DNA/RNA at scale within days and hours instead of weeks or months. Scientists around the world are using the technology in their own laboratories to accelerate the design-build-test paradigm for novel, high-value products for precision medicine, biologics drug discovery, vaccine and therapeutic development, genome editing, and cell and gene therapy. Codex DNA is a public company based in San Diego. For more information, visit codexdna.com.
Contact:
Richard Lepke
Director of Investor Relations
(619) 840-5392
RichardL@codexdna.com
FAQ
When is Codex DNA's presentation at the Jefferies Healthcare Conference?
How can I watch Codex DNA's presentation at the conference?
What technology does Codex DNA offer for DNA synthesis?
What markets does Codex DNA serve with its technology?
What is the ticker symbol for Codex DNA?
